Events

Horizon Implementation Day: Grant Management in Horizon Europe
NOV
Tue
05
09:30 - 13:00

This was 1 year ago

Location

webinar

Programmes
Horizon Europe HorizonEU L+F

The Commission gives a webinar tackling the following details of grant management:

  • amendment process
  • reporting and payments
  • fraud prevention, detection and corrections

A Q&A session with SLIDO is foreseen.

The programme and the link to the You Tube live stream can be found on this link. No prior registration is requested.

You can also go directly to the Commission You tube channel: EU Science & Innovation - YouTube (tab live).

Details about grant preparation will be explained in a webinar by the Commission on 16/10 (cfr. our event calendar).

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.